- Report
- April 2025
- 50 Pages
Global
From €2502EUR$2,650USD£2,146GBP
Nepinalone is a respiratory drug used to treat a variety of conditions, including asthma, chronic obstructive pulmonary disease (COPD), and bronchitis. It is a long-acting beta-agonist (LABA) that works by relaxing the muscles in the airways, allowing more air to flow through them. It is often used in combination with an inhaled corticosteroid (ICS) to provide better control of symptoms.
Nepinalone is available in both brand-name and generic forms, and is available in a variety of dosage forms, including tablets, capsules, and inhalers. It is typically taken once or twice daily, depending on the severity of the condition being treated.
The Nepinalone market is highly competitive, with a number of companies offering products. Some of the major players in the market include GlaxoSmithKline, Merck, Pfizer, AstraZeneca, and Novartis. Show Less Read more